Immucell (ICCC) Operating Income Growth (1y) (2011 - 2026)
Powered by 
Analysis
Immucell (ICCC) Operating Income Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 14.08% |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | -10.00% |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 12.73% |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 42.82% |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | 239.72% |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -14.07% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 239.72% |
| Dec 31, 2025 | -109.33% |
| Sep 30, 2025 | 103.49% |
| Jun 30, 2025 | 141.08% |
| Mar 31, 2025 | 472.48% |
| Sep 30, 2024 | 51.45% |
| Jun 30, 2024 | -6.29% |
| Mar 31, 2024 | 86.70% |
| Sep 30, 2023 | -91.97% |
| Jun 30, 2023 | -110.74% |
| Mar 31, 2023 | -495.37% |
| Dec 31, 2022 | -1,223.53% |
| Sep 30, 2022 | -327.52% |
| Jun 30, 2022 | -387.23% |
| Mar 31, 2022 | 252.31% |
| Dec 31, 2021 | 122.92% |
| Sep 30, 2021 | 207.75% |
| Jun 30, 2021 | 131.18% |
| Mar 31, 2021 | -290.28% |
| Dec 31, 2020 | -161.63% |